Rapid quantitative serological test for detection of infection with Mycobacterium leprae, the causative agent of leprosy.
Leprosy remains an important health problem in a number of regions. Early detection of infection, followed by effective treatment, is critical to reduce disease progression. New sensitive and specific tools for early detection of infection will be a critical component of an effective leprosy elimination campaign. Diagnosis is made by recognizing clinical signs and symptoms, but few clinicians are able to confidently identify these. Simple tests to facilitate referral to leprosy experts are not widely available, and the correct diagnosis of leprosy is often delayed. In this report, we evaluate the performance of a new leprosy serological test (NDO-LID). As expected, the test readily detected clinically confirmed samples from patients with multibacillary (MB) leprosy, and the rate of positive results declined with bacterial burden. NDO-LID detected larger proportions of MB and paucibacillary (PB) leprosy than the alternative, the Standard Diagnostics leprosy test (87.0% versus 81.7% and 32.3% versus 6.5%, respectively), while also demonstrating improved specificity (97.4% versus 90.4%). Coupled with a new cell phone-based test reader platform (Smart Reader), the NDO-LID test provided consistent, objective test interpretation that could facilitate wider use in nonspecialized settings. In addition, results obtained from sera at the time of diagnosis, versus at the end of treatment, indicated that the quantifiable nature of this system can also be used to monitor treatment efficacy. Taken together, these data indicate that the NDO-LID/Smart Reader system can assist in the diagnosis and monitoring of MB leprosy and can detect a significant number of earlier-stage infections.
Infectious Disease Research Institute, Seattle, Washington, USA.
Malcolm S
MS
Duthie
Marivic F
MF
Balagon
Armi
A
Maghanoy
Florenda M
FM
Orcullo
Marjorie
M
Cang
Ronaldo Ferreira
RF
Dias
Marco
M
Collovati
Steven G
SG
Reed
D058491:Bacterial Load / Q000379:methods*; D040421:Cell Phone; D016903:Drug Monitoring / Q000379:methods*; D006801:Humans; D007918:Leprosy / Q000175:diagnosis* / Q000382:microbiology*; D009166:Mycobacterium leprae / Q000302:isolation & purification*; D012680:Sensitivity and Specificity; D012698:Serologic Tests / Q000379:methods